Mucositis reduction with probiotics in children with cancer: a randomised-controlled feasibility study
- 30 June 2021
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 107 (3), 259-264
- https://doi.org/10.1136/archdischild-2020-319968
Abstract
Background A recent systematic review and meta-analysis identified a paucity of randomised-controlled trials (RCTs) investigating the use of probiotics to reduce or prevent mucositis and infection in children with cancer. Objective This study evaluated the feasibility of undertaking an RCT and investigated the efficacy of probiotics for reducing or preventing mucositis and infection in children with cancers. Setting The Paediatric Oncology and Haematology department at Leeds Teaching Hospital, UK. Patients Children aged 1 year or older, receiving chemotherapies likely to cause mucositis. Interventions Participants were randomised to receive the probiotic or placebo on day 1–14 of a chemotherapy cycle. Participants were also required to complete a patient diary for 21 days. Main outcome measures To assess whether it is feasible to recruit children diagnosed with cancer who are at risk of developing mucositis to an adequately powered RCT. Results Between May and November 2019, 34 out of 39 eligible participants were approached. Ten patients were recruited (4 probiotic and 6 placebo) of which 2 participants withdrew. Seven participants partially completed the diary but only two participants completed 80% or more. Eligible participants appeared to prefer giving informal verbal feedback when in direct contact with research and healthcare professionals. Conclusion This study demonstrated that recruitment needs to be improved prior to undertaking an adequately powered RCT. Trial registration number NCT03785938.Keywords
This publication has 14 references indexed in Scilit:
- Validation of the Children’s International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCTBritish Journal of Cancer, 2013
- Parents’ Agendas in Paediatric Clinical Trial Recruitment Are Different from Researchers’ and Often Remain Unvoiced: A Qualitative StudyPLOS ONE, 2013
- VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo‐Controlled, Double‐Blind, Crossover StudyJournal of Pediatric Gastroenterology and Nutrition, 2010
- Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative ColitisThe American Journal of Gastroenterology, 2009
- Parental Factors Impacting the Enrollment of Children in Cardiac Critical Care Clinical TrialsPediatric Cardiology, 2007
- Parental consent in paediatric clinical researchArchives of Disease in Childhood, 2005
- Estimating the Cost of Illness in Colorectal Cancer Patients Who Were Hospitalized for Severe Chemotherapy-Induced DiarrheaCanadian Journal of Gastroenterology, 2005
- Role of bacteria in experimental colitisBest Practice & Research Clinical Gastroenterology, 2003
- The Consequences of Diarrhea Occurring During Chemotherapy for Colorectal Cancer: A Retrospective StudyThe Oncologist, 2000
- Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitisAlimentary Pharmacology & Therapeutics, 1999